Last reviewed · How we verify
NCT03144336: MOTIVES
Using Mobile Technology and Incentives With Men Who Have Sex With Men and Transgender Women for HIV Prevention
NA trial testing Information provision in HIV Infections in 217 participants. Completed in 23 August 2019.
23 August 2019
Quick facts
| Lead sponsor | RAND |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 217 |
| Start date | 24 May 2017 |
| Primary completion | 23 August 2019 |
| Estimated completion | 23 August 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Information provision
- Weekly quizzes
- Rewards for testing HIV-negative
Conditions studied
- HIV Infections — all drugs for HIV Infections →
- HIV — all drugs for HIV →
Sponsor
RAND — full company profile →
Who can join
18 and older, any sex, with HIV Infections or HIV. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This project called Mobile Technology and Incentives (MOTIVES) aims to increase engagement with HIV prevention information and improve testing frequency among Latino/a men who have sex with men (MSM) and transgender women (TGW). Its primary goal is to develop and test the feasibility and acceptability of an HIV prevention intervention that uses text messages in combination with prizes to improve HIV prevention information retention and HIV testing frequency. The project will be conducted in collaboration with Bienestar Human Services, Inc. (Bienestar) in Los Angeles County. Phase 1 consists of formative research (focus groups n=9) with MSM (n=52) and TGW (n=39) to complement the previously collected pilot data (2014-2015) to finalize the planned intervention. In Phase 2, the intervention will be piloted among 5 individuals, implemented, and tested in a small, randomized controlled trial (RCT) among 200 Latino MSM and TGW from Bienestar's HIV testing sites. Interested individuals will be screened for eligibility upon testing HIV-negative (those testing positive will be linked to HIV services as required by Bienestar's standard of care). Eligible participants will be randomized into either the intervention or control group that will both receive study information weekly and will be invited to get tested for HIV every three months. Participants in the intervention group will be able to accumulate rewards points for correctly answering weekly quizzes regarding the HIV prevention information; these reward incentives aim to encourage retention in the study and improve HIV prevention knowledge engagement and recollection. Every three months those in the intervention group can win a prize based on testing HIV-negative at least once during that time period. The chance of winning will increase based on the number of reward points a participant accumulates by correctly answering questions on the weekly quizzes. The primary outcome measures will include HIV-preventive knowledge and frequency of HIV testing (at least once every 3 months). In Phase 3 of the study, the investigators will conduct 6 focus groups with approximately 5-8 participants each among MSM (n=3) and TGW (n=1) study participants, testing site staff (n=1), and administrative staff (n=1) to identify implementation challenges and areas for improvement; and estimate mission-critical design parameters with point and confidence interval estimates to inform a subsequent, fully-powered R01 application.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Behavioral economics-based incentives supported by mobile technology on HIV knowledge and testing frequency among Latino/a men who have sex with men and transgender women: Protocol for a randomized pilot study to test intervention feasibility and acceptability.
Linnemayr S, MacCarthy S, Kim A, Giguere R, et al · · 2018 · cited 25× · PMID 30290851 · DOI 10.1186/s13063-018-2867-1 -
The acceptability and feasibility of a pilot study examining the impact of a mobile technology-based intervention informed by behavioral economics to improve HIV knowledge and testing frequency among Latinx sexual minority men and transgender women.
MacCarthy S, Mendoza-Graf A, Wagner Z, L Barreras J, et al · · 2021 · cited 12× · PMID 33579242 · DOI 10.1186/s12889-021-10335-5 -
Brief Report: Using Behavioral Economics to Increase HIV Knowledge and Testing Among Latinx Sexual Minority Men and Transgender Women: A Quasi-Experimental Pilot Study.
MacCarthy S, Wagner Z, Barreras JL, Kim A, et al · · 2020 · cited 12× · PMID 32931684 · DOI 10.1097/qai.0000000000002433
Verify or expand the search:
- PubMed search for NCT03144336
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Information provision
Trials testing the same drug.
- NCT04917822 — Project KING: To Strengthen Parent-child Relationship and Adaptation · NA · completed
- NCT03350269 — Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates · NA · terminated
Other recruiting trials for HIV Infections
Currently open trials in the same condition.
- NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
- NCT07202546 — A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · recruiting
- NCT06694753 — Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall · Phase 1 · recruiting
- NCT07235852 — Pilot Testing Into the Feasibility of the Developed Cognitive Behavioral Therapy Intervention · NA · recruiting
- NCT06665646 — Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Ad · Phase 1 · recruiting
Other RAND trials
Trials by the same sponsor.
- NCT06048328 — Game Changers for Family Planning Peer Advocacy Program · Phase 1, PHASE2 · not yet recruiting
- NCT07072819 — Pilot of Training on 988 and Narcan · NA · completed
- NCT06699251 — Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat) · NA · recruiting
- NCT06949774 — INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND) · NA · recruiting
- NCT06827288 — Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03144336 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RAND
- Last refreshed: 10 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03144336.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing